Nanotechnology Now







Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > AusBiotech welcomes announcement on R&D Tax Credit

Abstract:
Following a lengthy and sustained campaign, the biotechnology community is today celebrating news that the much-needed Research & Development (R&D) Tax Credit will be delivered imminently, providing a major boost for innovative biotechnology companies and spill-over benefits for the community from biotechnologies.

AusBiotech welcomes announcement on R&D Tax Credit

Australia | Posted on June 15th, 2011

Treasurer, Wayne Swan and Senator Kim Carr, Minister of Industry, Innovation, Science and Research have announced in a joint media release an agreement that will see the Tax Credit legislation pass in the August sitting of the Senate and be effective from 1 July 2011 - thereby delivering the Tax Credit to provide a meaningful incentive and "landmark reform" for R&D in Australia.
Start-up innovation companies, especially biotechnology companies trading in loss, are set to be the big winners from the Tax Credit's 45% refundable component, and the legislation will also benefit large innovative companies by reducing the cost of conducting eligible R&D activities in Australia by up to 10%, making Australia a more competitive location for conducting biomedical and pharmaceutical R&D.

AusBiotech and its membership have been strong and unwavering advocates for the move to a tax credit since its recommendation by Dr Terry Cutler in the Innovation Review of 2008, as good for the biotechnology sector and for innovative Australian companies generally - and therefore welcome the long-awaited news with enthusiasm.

The two Bills that make up the legislation are awaiting debate in the Senate, more than two years after the R&D Tax Credit was announced in May 2009. Since the announcement of the policy, AusBiotech has made four substantive submissions on the R&D Tax Credit and produced 11 case studies on how the incentive will benefit R&D in Australia, after extensive consultations with members.
AusBiotech CEO, Dr Anna Lavelle said: "Today is the result of more than two years of advocating, consultation and working toward a good policy for innovation, however the work is not done yet. The Bill still needs to officially pass into law, and we support its passage and eagerly await the moment."

"The biggest winners from the Tax Credit will be those companies in their early stages with turnover of less than $20million with no commercial production yet, which are able to cash out the refundable credit if in tax loss. The Tax Credit will provide greater incentives across the whole innovation industry, as well as vital support for start-up and small biotechnology companies, which is well targeted to increase R&D expenditure among these companies."

Dr Lavelle also welcomed news that the Government, with support from the Greens, will pursue an amendment to the Tax Credit program to provided quarterly payments of cash refunds, instead of annual payments, as recommended in AusBiotech's February 2010 submission in response to the 'exposure draft' of the Tax Laws Amendment (Research and Development) Bill 2010.

AusBiotech has always advocated for payments on a quarterly basis to assist companies manage cash flow. A survey conducted by AusBiotech as part of a series of tax credit briefings in July 2009, indicated the timing of the receipt of tax credit payments (i.e. quarterly or annually) will be a critical factor in its value as an incentive for additional R&D activities.

The crossbench support will mean the implementation date is 1 July 2011; and a provision will be introduced to make quarterly payments available to firms in tax loss from 1 January 2014.

Because the Bills have a degree of retrospectivity, to give business certainty in their planning, the crossbench Senators have agreed to an early announcement of their intent to support the Bill. This allows time for discussions with intermediaries such as industry organisations and tax consultants about how the Tax Credit will operate.

Dr Lavelle said: "We are heartened by the news that the Tax Credit is about to become a reality and the intention to pursue quarterly payment demonstrates that the Government's willingness to listen to small innovation companies and the Greens' genuine support for legislation that will enhance R&D, and in particular legislation that would stimulate additional R&D in small and medium companies."

The passing of the Tax Credit legislation will realise the recommendations of the 2010 Senate Inquiry that recommended the Tax Credit be implemented as soon as possible, as well as the proposal in the 2011 Australian Business Foundation report by Dr Nicholas Gruen of Lateral Economics, that the new R&D Tax Credit scheme should be passed into law.

The report said the further delay in passing the legislation "would not only delay the increases in R&D investment from small firms that could be expected from the changes, but could also retard investment in R&D by smaller firms, even if it were viable under the current regime." (2011: The BERD in the hand: Supporting Business Investment in Research and Development.)

####

About AusBiotech
AusBiotech is Australia's voice on biotechnology, and represents more than 3,000 members, encompassing medicines, medical diagnostics and devices, agriculture, alternative fuels and climate change.

For more information, please click here

Contacts:
Lorraine Chiroiu
AusBiotech
Communications Manager
03 9828 1414 / 0429 801 118

Copyright © AusBiotech

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Govt.-Legislation/Regulation/Funding/Policy

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

UT Dallas engineers twist nanofibers to create structures tougher than bulletproof vests March 27th, 2015

Novel nanoparticle therapy promotes wound healing March 27th, 2015

Designer's toolkit for dynamic DNA nanomachines: Arm-waving nanorobot signals new flexibility in DNA origami March 27th, 2015

Announcements

Nanoscale worms provide new route to nano-necklace structures March 29th, 2015

Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015

A first glimpse inside a macroscopic quantum state March 28th, 2015

DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015

Alliances/Partnerships/Distributorships

NXP and GLOBALFOUNDRIES Announce Production of 40nm Embedded Non-Volatile Memory Technology: Co-developed technology to leverage GLOBALFOUNDRIES 40nm process technology platform March 24th, 2015

Young NTU Singapore spin-off clinches S$4.3 million joint venture with Chinese commercial giant March 23rd, 2015

Halas, Nordlander awarded Optical Society's R.W. Wood Prize: Rice University researchers recognized for pioneering nanophotonics March 21st, 2015

EU Funded PCATDES Project has completed its half-period with success March 19th, 2015

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2015 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE